1. CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance. Issue 6 (June 1995) Authors: Zandecki, M; Facon, T; Bernardi, F; Izydorczyk, V; Dupond, L; François, M; Reade, R; Iaru, T; Bauters, F; Cosson, A Journal: Journal of clinical pathology Issue: Volume 48:Issue 6(1995) Page Start: 548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P07: RESULTS FROM THE CC-220-MM-001 DOSE-EXPANSION PHASE OF IBERDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA. (5th April 2022) Authors: van de Donk, N. W. C. J; Popat, R; Hulin, C; Jagannath, S; Oriol, A; Richardson, P. G; Facon, T; Weisel, K; Larsen, J. T; Minnema, M; Abdallah, A; Badros, A. Z; Knop, S; Stadtmauer, E. A; Chen, M; Nguyen, T. V; Amin, A; Peluso, T; Lonial, S Journal: HemaSphere Issue: Volume 6(2022)Supplement 2 Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0255 A new bone prognostic factor in multiple myeloma (mm): level serum cross-laps (ctx) at diagnosis. (1st June 2001) Authors: Duché, A; Leleu, X; Duhamel, A; Delannoy, V; Facon, T; Brazier, M Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗